[1]
M. Zade, “Targeting Neurodegeneration in Alzheimer’s Disease: A Comprehensive Evaluation of Andrographolide as a Potential Therapeutic Agent in the Management and Treatment of Cognitive Decline”, JIMP, vol. 1, no. 02, pp. 20–32, Aug. 2024.